NCT03820713View on ClinicalTrials.gov

Evaluation of the Feasibility, Safety, Initial Efficacy and Clinical Usability of FuseX Anti-Adhesion System

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 9, 2018

Primary Completion Date

July 15, 2020

Study Completion Date

July 15, 2020

Conditions
Reduction of Postoperative Adhesions
Interventions
PROCEDURE

Concentrate of plasma coagulation factors

The plasma concentrate of coagulation factors is applied to the surgical site.

PROCEDURE

0.9% saline

Control group receives an identical syringe and applicator generated by processing normal saline 0.9% instead of plasma.

Trial Locations (2)

LT-47144

Kaunas Clinical Hospital, Kaunas

LT-50009

Hospital of Lithuanian University of Health Sciences Kauno Klinikos, Kaunas

Sponsors
All Listed Sponsors
lead

Eio Biomedical Ltd.

INDUSTRY